Search

everythinglearnresearchcommunity

for

Search:↓

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

New compounds may soon be tested to treat excessive hair growth in women.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Juniperus plants contain compounds with potential for developing various medical treatments.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Personalized treatment plans are important for people with alopecia areata.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.